An intellectual virtue "vaccination" for physician-pharmaceutical industry interactions
- PMID: 25319170
- DOI: 10.1097/ACM.0000000000000525
An intellectual virtue "vaccination" for physician-pharmaceutical industry interactions
Abstract
The pharmaceutical industry's wide range of interactions with physicians, trainees, and other medical professionals--interactions that include information transfer and financial incentives--has been the source of undue influences, especially on physicians' prescription behavior. Current literature has mainly been focused on the financial element of these influences, and the problems in medical professional-pharmaceutical industry interactions are mainly viewed in terms of conflicts of interest. There is often the assumption that physicians are intellectually competent but biased because of financial incentives.The author rejects that assumption and proposes an alternative explanation for the observed influence of the pharmaceutical industry on physicians' behavior by emphasizing the importance of the information-transfer side of the interactions and maintaining that physicians and other medical professionals need certain intellectual virtues (i.e., competencies) to properly assess the information, which is often unreliable and biased. These virtues are necessary for the practice of modern medicine and include mindfulness, the ability to understand practical implications of newly found evidence, to consider alternative explanations of data, to recognize and correct errors, to decide on the best available evidence, and to tailor that to the needs and values of individual patients. On the basis of this view, the author recommends that the best solution for the observed problems in physician-pharmaceutical industry interactions is to "vaccinate" physicians and other medical professionals by increasing efforts to inculcate the necessary intellectual virtues early in medical education and fostering them throughout those individuals' professional lives.
Comment in
-
Intellectual Virtue Vaccination Schedules Need to Include Boosters.Acad Med. 2015 Oct;90(10):1293. doi: 10.1097/ACM.0000000000000868. Acad Med. 2015. PMID: 27002881 No abstract available.
-
In Reply to Falk.Acad Med. 2015 Oct;90(10):1293. doi: 10.1097/ACM.0000000000000889. Acad Med. 2015. PMID: 27002882 No abstract available.
Similar articles
-
Debunking myths in physician-industry conflicts of interest.Am J Ophthalmol. 2008 Aug;146(2):159-71. doi: 10.1016/j.ajo.2008.04.007. Epub 2008 Jun 6. Am J Ophthalmol. 2008. PMID: 18538299
-
Physician's prescription and pharmaceutical industry's influence - where have the ethics gone?J Pak Med Assoc. 2024 Nov;74(11 (Supple-12)):S44-S46. doi: 10.47391/JPMA.AKU-EPP-09. J Pak Med Assoc. 2024. PMID: 39648175 Review.
-
Building legitimacy by criticising the pharmaceutical industry: a qualitative study among prescribers and local opinion leaders.Swiss Med Wkly. 2015 Dec 10;145:w14240. doi: 10.4414/smw.2015.14240. eCollection 2015. Swiss Med Wkly. 2015. PMID: 26661626
-
Proposed guidelines for housestaff interaction with pharmaceutical companies.Ann R Coll Physicians Surg Can. 1993 Oct;26(5):291-3. Ann R Coll Physicians Surg Can. 1993. PMID: 15362243
-
Conflict of interest in the physician interface with the biomedical industry.Emerg Med Clin North Am. 2006 Aug;24(3):671-85. doi: 10.1016/j.emc.2006.05.008. Emerg Med Clin North Am. 2006. PMID: 16877136 Review.
Cited by
-
Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space.Health Care Anal. 2022 Mar;30(1):35-56. doi: 10.1007/s10728-021-00438-w. Epub 2021 Nov 11. Health Care Anal. 2022. PMID: 34761311 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources